62686

Solvency II's biggest unintended consequences

In part two of a Q&A to accompany the launch of his book on Solvency II, Karel Van Hulle discusses the impact of the directive, and how the insurance sector should prepare for sustainability, Brexit and new technologies

62570

Canopius: looking east and west for growth

This year's deals involving AmTrust and Samsung have given the 16-year-old Lloyd's operation a fresh impetus, as chairman Michael Watson explains to David Walker

62566

Climate risk in the US: time to stand up

Trenchant politics, vested interests, short-term thinking ... tackling climate change in the US is an uphill battle. Washington insurance commissioner Mike Kreidler tells Sarfraz Thind about the difficulties of standing up to the status quo

62599

Insurers push for dual-rate approach to Ogden

The change in the Ogden rate prompted surprise and disappointment from insurers. Their hopes for a fairer settlement are now pinned on the next round of reforms, as Christopher Cundy and Paul Walsh report

62554

What's next for the MA and VA?

More than €100bn of capital relief is provided by Solvency II's matching and volatility adjustments, but they are far from uncontroversial. As the European Commission begins to consider reforms, Christopher Cundy reports on the problems and possible solutions

62336

Comment: on the Solvency II matching adjustment and credit risk capital

Craig Turnbull argues whether the matching adjustment results in EU life insurers holding a prudent amount of capital to support the long-term credit default risk in their fixed income portfolios

62342

International capital standards: the US's chorus of disapproval

Development of the global insurance capital standard (ICS) has always been controversial. But the level of ire expressed by the US government, regulators and insurers at this week's NAIC conference was unprecedented. Sarfraz Thind reports

62272

Decoding IFRS 17 from an investment perspective

Efforts by the International Accounting Standards Board (IASB) to clarify the definition of investment components within an insurance contract have been welcomed by some stakeholders. However, others argue a new proposal from the board could spark confusion. Cintia Cheong explains

62231

Six ingredients needed for an effective consumer risk metric

How should insurers communicate the risks and benefits of their products to potential retail customers? A recent paper from the UK Institute and Faculty of Actuaries investigated this question and came up with some surprising results. Christopher Cundy explains

62206

"The Solvency II review is a Herculean task for regulators"

Talanx's chief risk officer Gerhard Stahl talks to David Walker about the 2020 review of Solvency II, how to improve risk reporting, and the story behind ESG integration